Department of Pediatrics, Cardiovascular Research Centre, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada ; Department of Pharmacology, Cardiovascular Research Centre, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.
PLoS One. 2013 Aug 27;8(8):e71794. doi: 10.1371/journal.pone.0071794. eCollection 2013.
Matrix metalloproteinase-2 (MMP-2) is a key intra- and extra-cellular protease which contributes to several oxidative stress related pathologies. A molecular understanding of 72 kDa MMP-2 activity, directly mediated by S-glutathiolation of its cysteine residues in the presence of peroxynitrite (ONOO(-)) and by phosphorylation of its serine and threonine residues, is essential to develop new generation inhibitors of intracellular MMP-2. Within its propeptide and collagen binding domains there is an interesting juxtaposition of predicted phosphorylation sites with nearby cysteine residues which form disulfide bonds. However, the combined effect of these two post-translational modifications on MMP-2 activity has not been studied. The activity of human recombinant 72 kDa MMP-2 (hrMMP-2) following in vitro treatments was measured by troponin I proteolysis assay and a kinetic activity assay using a fluorogenic peptide substrate. ONOO(-) treatment in the presence of 30 µM glutathione resulted in concentration-dependent changes in MMP-2 activity, with 0.1-1 µM increasing up to twofold and 100 µM attenuating its activity. Dephosphorylation of MMP-2 with alkaline phosphatase markedly increased its activity by sevenfold, either with or without ONOO(-). Dephosphorylation of MMP-2 also affected the conformational structure of the enzyme as revealed by circular dichroism studies, suggesting an increase in the proportion of α-helices and a decrease in β-strands compared to the phosphorylated form of MMP-2. These results suggest that ONOO(-) activation (at low µM) and inactivation (at high µM) of 72 kDa MMP-2, in the presence or absence of glutathione, is also influenced by its phosphorylation status. These insights into the role of post-translational modifications in the structure and activity of 72 kDa MMP-2 will aid in the development of inhibitors specifically targeting intracellular MMP-2.
基质金属蛋白酶-2(MMP-2)是一种关键的细胞内外蛋白酶,参与多种与氧化应激相关的病理过程。要开发新一代细胞内 MMP-2 抑制剂,就必须深入了解 72 kDa MMP-2 活性,其活性直接由过氧亚硝酸盐(ONOO(-))介导的半胱氨酸残基 S-谷胱甘肽化以及丝氨酸和苏氨酸残基磷酸化来调节。在其前肽和胶原结合结构域中,存在着预测的磷酸化位点与附近形成二硫键的半胱氨酸残基的有趣并置。然而,这两种翻译后修饰对 MMP-2 活性的综合影响尚未得到研究。通过肌钙蛋白 I 蛋白水解测定法和使用荧光肽底物的动力学活性测定法,测量了人重组 72 kDa MMP-2(hrMMP-2)在体外处理后的活性。在 30 µM 谷胱甘肽存在下,ONOO(-)处理会导致 MMP-2 活性发生浓度依赖性变化,0.1-1 µM 浓度增加两倍,而 100 µM 浓度则会抑制其活性。碱性磷酸酶对 MMP-2 的去磷酸化作用使 MMP-2 的活性显著增加了七倍,无论是否存在 ONOO(-)。MMP-2 的去磷酸化作用还影响了酶的构象结构,如圆二色性研究所示,与磷酸化形式的 MMP-2 相比,这表明α-螺旋的比例增加,β-折叠的比例减少。这些结果表明,72 kDa MMP-2 的 ONOO(-)激活(在低 µM 时)和失活(在高 µM 时),无论是否存在谷胱甘肽,也受到其磷酸化状态的影响。这些对 72 kDa MMP-2 结构和活性的翻译后修饰作用的深入了解,将有助于开发专门针对细胞内 MMP-2 的抑制剂。